ALEXANDRA HOF: Open Payments
NPI 1942908959 · BALLWIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 48 payments from 13 companies in 2025. Trend: 2023 $834 · 2024 $1,165 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $155 |
| ABBVIE INC. | 11 | $137 |
| Novo Nordisk Inc | 4 | $75 |
| Edwards Lifesciences Corporation | 3 | $73 |
| Sumitomo Pharma America, Inc. | 3 | $52 |
| Astellas Pharma US Inc | 2 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Lilly USA, LLC | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: NURTEC ODT, Wegovy, UBRELVY, GEMTESA, QULIPTA, SAPIEN 3 Ultra RESILIA, Veozah, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
